The financial pressures placed on academic departments of psychiatry
make the offers of assistance from pharmaceutical companies very
attractive. The authors provide a sequential three-step decision-making
approach to help the academic physician and the psychiatry department
address the ethical issues involved in any given interaction with a
pharmaceutical company. They also provide examples of the application of
these guidelines.
Abstract Teaser